#USA #Kessler Topaz #Securities Fraud #Radnor #Hims & Hers Health

Kessler Topaz Meltzer & Check, LLP Reminds Hims Shareholders of Important Deadline in Class Action Lawsuit

The prominent law firm, Kessler Topaz Meltzer & Check, LLP, has made an urgent announcement to investors regarding Hims & Hers Health, Inc., commonly referred to as Hims. This update pertains to the deadline for participating in a class action lawsuit alleging securities fraud against the company. This case has been filed in the United States District Court for the Northern District of California and extends to those who acquired Hims securities between April 29, 2025, and June 23, 2025.

What are the Key Details?

The firm has indicated that investors have until August 25, 2025, to seek appointment as a lead plaintiff in this class action lawsuit. The lead plaintiff is typically the individual or group of investors with the most significant financial interest in the outcome of the case, and who will represent the interests of all affected investors in the litigation process. If investors do not opt to pursue leadership in the case, they can still remain a member of the class without any obligation.

Allegations in the Lawsuit

The lawsuit outlines several allegations against Hims & Hers Health, Inc. It claims that throughout the class period, the company engaged in deceptive practices, which included:
1. Promotion of Knockoff Products: The firm alleges that Hims was involved in the promotion and sale of illegitimate versions of Wegovy, which could jeopardize patient safety.
2. Misleading Statements: The defendants are accused of making false statements regarding the health of the company's operations and its prospects, without disclosing the significant risks associated with their actions.
3. Termination Risks: Furthermore, the lawsuit alleges that due to the deceptive marketing practices, there was a substantial risk of Hims' collaboration with Novo Nordisk being terminated.

These points underline the critical accusations against Hims, suggesting that the firm may have knowingly misled investors regarding their business practices.

How to File a Claim

Investors who believe they have suffered losses as a result of this alleged misconduct are encouraged to contact Kessler Topaz Meltzer & Check, LLP directly. For more information or to participate in the case, they can visit the firm's website or reach out via the contact details provided in the announcement.

About Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP is widely recognized for its legal expertise in investor advocacy, focusing on class actions for cases of securities fraud and corporate misconduct. The firm has built a strong reputation and has successfully recovered billions for affected parties over the years. They aim to protect investors from fraudulent activities perpetrated by corporations and other fiduciaries.

To sum up, Hims & Hers Health, Inc. shareholders facing potential losses should take this deadline seriously and consider their options for involvement in the ongoing lawsuit. For those needing more guidance, contacting the firm is a recommended first step.